Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

    Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, Peter & Jørgensen, M. E., 2021, In: Diabetes Care. 44, 3, 7 p., dc202586.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A catalog of genetic loci associated with kidney function from analyses of a million individuals

    Wuttke, M., Li, Y., Li, M., Ahluwalia, Tarun Veer Singh, Christensen, K., LifeLines Cohort Study, L. C. S., Rossing, Peter, Teumer, A., Köttgen, A. & Pattaro, C., 2019, In: Nature Genetics. 51, p. 957-972

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

    Agarwal, R., Pitt, B., Palmer, B. F., Kovesdy, C. P., Burgess, E., Filippatos, G., Małyszko, J., Ruilope, L. M., Rossignol, P., Rossing, Peter, Pecoits-Filho, R., Anker, S. D., Joseph, A., Lawatscheck, R., Wilson, D., Gebel, M. & Bakris, G. L., 2023, In: Clinical Kidney Journal. 16, 2, p. 293-302 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes

    Van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., William Rayner, N., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., McKeigue, P. M., Valo, E., Forsblom, C., Harjutsalo, V., Perna, A., Rurali, E., Loredana Marcovecchio, M., Igo, R. P., Lajer, M., Ahluwalia, T. S. & 7 others, Linneberg, Allan René, Witte, D. R., Grarup, Niels, Pedersen, Oluf Borbye, Hansen, Torben, Rossing, Peter & SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, S. M. F. M. A. M. H. E. F. I. D. T. (. C., 2018, In: Diabetes. 67, 7, p. 1414-1427 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes

    Frimodt-Møller, M., Hansen, T. W., Rasmussen, D. G. K., Theilade, S., Nielsen, S. H., Karsdal, M. A., Genovese, F. & Rossing, Peter, 2019, In: Acta Diabetologica. 56, 6, p. 711-712 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

    Persson, F., Borg, Rikke & Rossing, Peter, 1 Apr 2021, In: Annals of Translational Medicine. 9, 8, p. 716-716 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria

    Ahluwalia, T. S., Schulz, C-A., Waage, J., Skaaby, T., Sandholm, N., van Zuydam, N., Charmet, R., Bork-Jensen, J., Almgren, P., Thuesen, B. H., Bedin, M., Brandslund, I., Christensen, C. K., Linneberg, A., Ahlqvist, E., Groop, P-H., Hadjadj, S., Tregouet, D-A., Jorgensen, M. E., Grarup, N. & 9 others, Pedersen, Oluf Borbye, Simons, M., Groop, L., Orho-Melander, M., McCarthy, M. I., Melander, O., Rossing, Peter, Kilpeläinen, Tuomas O. & Hansen, Torben, 2019, In: Diabetologia. 62, 2, p. 292-305

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Kidney International. 100, 1, p. 215-224

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International. 101, 1, p. 174-184 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes

    Bakris, G. L., Ruilope, L. M., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Fried, L., Roy-Chaudhury, P., Sarafidis, P., Ahlers, C., Brinker, M., Joseph, A., Lawatscheck, R., Agarwal, R. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney International. 103, 1, p. 196-206 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 12937790